Indications for Use: 

Omeprazole PSK for intravenous administration is indicated as an alternative to oral therapy (tablets, capsules) in adults for the prevention and treatment of the following conditions:

• Gastric and duodenal ulcers 
• Erosive and ulcerative lesions of the stomach associated with the intake of anti-inflammatory and analgesic drugs (nonsteroidal anti-inflammatory drugs) 
• Erosive and ulcerative lesions of the duodenum associated with the intake of nonsteroidal anti-inflammatory drugs 
• Stress ulcers associated with certain neuropsychiatric disorders such as depression, stress, or anxiety 
• Symptomatic gastroesophageal reflux disease without changes in the esophageal mucosa 
• Reflux esophagitis (inflammation of the esophageal mucosa due to reflux of stomach contents) 
• Zollinger-Ellison syndrome (pancreatic tumor that stimulates excess acid production in the stomach) 
• Prevention of aspiration of stomach contents into the respiratory tract during anesthesia (Mendelson's syndrome)
  

This product is included in the Essential Drug List (EDL).

Regulatory Status: Rx only

THERE ARE CONTRAINDICATIONS AND DRUG INTERACTIONS. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of the Omeprazole PSK (omeprazole) leaflet, please visit this website: https://grls.rosminzdrav.ru/Default.aspx.